Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Methods Enzymol. 2023;682:137-185. doi: 10.1016/bs.mie.2022.09.004. Epub 2022 Dec 26.
Traditional mass spectrometry-based glycoproteomic approaches have been widely used for site-specific N-glycoform analysis, but a large amount of starting material is needed to obtain sampling that is representative of the vast diversity of N-glycans on glycoproteins. These methods also often include a complicated workflow and very challenging data analysis. These limitations have prevented glycoproteomics from being adapted to high-throughput platforms, and the sensitivity of the analysis is currently inadequate for elucidating N-glycan heterogeneity in clinical samples. Heavily glycosylated spike proteins of enveloped viruses, recombinantly expressed as potential vaccines, are prime targets for glycoproteomic analysis. Since the immunogenicity of spike proteins may be impacted by their glycosylation patterns, site-specific analysis of N-glycoforms provides critical information for vaccine design. Using recombinantly expressed soluble HIV Env trimer, we describe DeGlyPHER, a modification of our previously reported sequential deglycosylation strategy to yield a "single-pot" process. DeGlyPHER is an ultrasensitive, simple, rapid, robust, and efficient approach for site-specific analysis of protein N-glycoforms, that we developed for analysis of limited quantities of glycoproteins.
传统的基于质谱的糖蛋白质组学方法已被广泛用于分析特定位点的 N-糖型,但为了获得能够代表糖蛋白上大量 N-聚糖多样性的代表性样品,需要大量的起始材料。这些方法通常还包括复杂的工作流程和极具挑战性的数据分析。这些限制因素使得糖蛋白质组学无法适应高通量平台,并且分析的灵敏度目前还不足以阐明临床样本中的 N-聚糖异质性。作为潜在疫苗重组表达的包膜病毒的高度糖基化刺突蛋白是糖蛋白质组学分析的主要目标。由于刺突蛋白的免疫原性可能受到其糖基化模式的影响,因此对 N-糖型的特异性分析为疫苗设计提供了关键信息。我们使用重组表达的可溶性 HIV Env 三聚体描述了 DeGlyPHER,这是对我们之前报道的顺序去糖基化策略的修改,以产生“一锅法”过程。DeGlyPHER 是一种超灵敏、简单、快速、稳健且高效的方法,用于分析有限量糖蛋白的蛋白质 N-糖型,我们开发了该方法用于分析有限量的糖蛋白。